UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
------------------------------
Date of Report (Date of earliest event reported): February 26, 2004
Orthofix International N.V.
(Exact name of Registrant as specified in its charter)
Netherlands Antilles 0-19961 N/A
(State or other jurisdiction Commission File Number (I.R.S. Employer
of incorporation) Identification Number)
------------------------------
7 Abraham de Veerstraat
Curacao
Netherlands Antilles
011-59-99-465-8525
(Address of principal executive offices and telephone number, including area
code)
------------------------------
Item 12. Results of Operations and Financial Condition.
----------------------------------------------
The following information is furnished pursuant to Item 12, "Results of
Operations and Financial Condition." On February 26, 2004, Orthofix
International N.V. ("Orthofix") issued a press release announcing, among other
things, its results of operations for the quarter and year ended December 31,
2003. A copy of the press release is attached hereto as Exhibit 99.1 and is
incorporated by reference herein.
In addition, Orthofix announced in its press release dated February 26,
2004 that, excluding $1.0 million in litigation costs related to the KCI patent
infringement case, net income for the fourth quarter ended December 31, 2003
would have been $7.8 million, or $0.52 per share. For the year ended December
31, 2003, net income, excluding KCI litigation and after tax settlement costs
associated with the Office of Inspector General investigation of $3.8 million
and $1.1 million, respectively, would have been $29.6 million, or $2.02 per
share. Orthofix believes that this net income measure, excluding these
litigation and settlement costs, is a useful proxy for results from operations
because Orthofix did not incur related litigation or settlement costs in the
fourth quarter of 2002 or for the year ended December 31, 2002.
Exhibit
-------
99.1 Press release of Orthofix International N.V. dated February 26, 2004
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Dated: February 26, 2004
ORTHOFIX INTERNATIONAL N.V.
By: /S/ THOMAS HEIN
Name: Thomas Hein
Title: Chief Financial Officer